Trump announces plan to cut cost of weight loss drugs and expand access

Injectable versions of GLP-1s from Eli Lilly and Novo Nordisk will see reduced prices and broader coverage

Donald Trump announced a plan on Thursday to reduce the costs of some weight loss drugs for certain patients and expand access to them for people on public health insurance.

The agreement will make oral version of GLP-1s, which aren't yet to market but are expected to be approved in the coming months, available at $150 per month for starting doses.